SIAH1 ubiquitination-modified HMGCR inhibits lung cancer progression and promotes drug sensitivity through cholesterol synthesis
2023 · Cancer Cell International · 12 citations
https://doi.org/10.1186/s12935-023-02914-w
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
29
Citations
1
h-index
1
i10-index
Hongge Wu is an academic researcher from Wuhan Union Hospital. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Sarcoma Diagnosis and Treatment & HER2/EGFR in Cancer Research. The author has an h-index of 1, co-authored 3 publications.
Click to start Chat